What type of study is this?

Clinical and management differences in patients with active cancer and pulmonary embolism

View Full Paper

Ask AI

Bookmark

Authors

Analysis reveals treatment delays and symptom variations in patients with pulmonary embolism and active cancer.

Patients with active cancer presenting with PE are more likely to experience heart failure symptoms.
Treatment delays for thrombolysis are significant, averaging 46 hours for cancer patients compared to 20 hours for non-cancer patients.
Fibrinolysis is administered less frequently to active cancer patients, with 37.5% receiving it versus 57.0% of non-cancer patients.
The study involved 178 patients, with clinical differences noted primarily in symptom presentation and treatment approach.

Ferreira et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark